» Articles » PMID: 36808215

How to Manage Coagulopathies in Critically Ill Patients

Overview
Specialty Critical Care
Date 2023 Feb 22
PMID 36808215
Authors
Affiliations
Soon will be listed here.
Abstract

Coagulopathy is a severe and frequent complication in critically ill patients, for which the pathogenesis and presentation may be variable depending on the underlying disease. Based on the dominant clinical phenotype, the current review differentiates between hemorrhagic coagulopathies, characterized by a hypocoagulable and hyperfibrinolysis state, and thrombotic coagulopathies with a systemic prothrombotic and antifibrinolytic phenotype. We discuss the differences in pathogenesis and treatment of the common coagulopathies.

Citing Articles

The role of viscoelastic tests in the diagnosis of sepsis-induced coagulopathy (SIC).

Iba T, Helms J, Levy J Ann Intensive Care. 2025; 15(1):19.

PMID: 39873901 PMC: 11775350. DOI: 10.1186/s13613-025-01442-2.


Risk factor of postoperative pulmonary complications after colorectal cancer surgery: an analysis of nationwide inpatient sample.

Huang L, Luo J, Wang Y, Gan L, Xu N, Chen J Sci Rep. 2025; 15(1):2717.

PMID: 39837854 PMC: 11750964. DOI: 10.1038/s41598-024-84758-6.


Biomarkers of sepsis-induced coagulopathy: diagnostic insights and potential therapeutic implications.

Curtiaud A, Iba T, Angles-Cano E, Meziani F, Helms J Ann Intensive Care. 2025; 15(1):12.

PMID: 39821561 PMC: 11739444. DOI: 10.1186/s13613-025-01434-2.


Mitochondrial dysfunction is a major cause of thromboinflammation and inflammatory cell death in critical illnesses.

Iba T, Helms J, Maier C, Ferrer R, Levy J Inflamm Res. 2025; 74(1):17.

PMID: 39806233 DOI: 10.1007/s00011-025-01994-w.


Coagulation Factor XIII - Last to think about?.

Mahecic T, Konosic S, Noitz M, Bobinac M Blood Transfus. 2025; 23(1):70-74.

PMID: 39804745 PMC: 11841952. DOI: 10.2450/BloodTransfus.902.


References
1.
Hjorleifsson E, Sigurdsson M, Gudmundsdottir B, Sigurdsson G, Onundarson P . Prediction of survival in patients suspected of disseminated intravascular coagulation. Acta Anaesthesiol Scand. 2015; 59(7):870-80. DOI: 10.1111/aas.12537. View

2.
Kleinveld D, Hamada S, Sandroni C . Trauma-induced coagulopathy. Intensive Care Med. 2022; 48(11):1642-1645. DOI: 10.1007/s00134-022-06834-7. View

3.
Callcut R, Kornblith L, Conroy A, Robles A, Meizoso J, Namias N . The why and how our trauma patients die: A prospective Multicenter Western Trauma Association study. J Trauma Acute Care Surg. 2019; 86(5):864-870. PMC: 6754176. DOI: 10.1097/TA.0000000000002205. View

4.
Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C . The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost. 2012; 11(2):307-14. DOI: 10.1111/jth.12078. View

5.
Moore H, Moore E, Morton A, Gonzalez E, Fragoso M, Chapman M . Shock-induced systemic hyperfibrinolysis is attenuated by plasma-first resuscitation. J Trauma Acute Care Surg. 2015; 79(6):897-903. PMC: 4686159. DOI: 10.1097/TA.0000000000000792. View